P-21 A phase II trial of weekly paclitaxel in advanced non-small cell lung cancer non-suitable for platinum-based chemotherapy. Spanish lung cancer group/GECP 00-02

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S96
Author(s):  
Bartomeu Massutí ◽  
Carlos Camps ◽  
Pilar Garrido ◽  
JoséRamón Barceló ◽  
Núria Vin˜olas ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Weekly Paclitaxel ◽  
Small Cell Lung ◽  
Cancer Group ◽  
Platinum Based Chemotherapy

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy

2020 ◽  
Vol 21 (4) ◽  
pp. 357-364.e7 ◽  
Author(s):  
Susanne M. Arnold ◽  
Kari Chansky ◽  
Maria Q. Baggstrom ◽  
Michael A. Thompson ◽  
Rachel E. Sanborn ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Platinum Based Chemotherapy

scholarly journals Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer

2011 ◽  
Vol 6 (6) ◽  
pp. 1117-1120 ◽  
Author(s):  
Bryan J. Schneider ◽  
Shirish M. Gadgeel ◽  
Nithya Ramnath ◽  
Antoinette J. Wozniak ◽  
Grace K. Dy ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Maintenance Therapy ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Platinum Based Chemotherapy ◽  
Extensive Stage
Sign in / Sign up

Export Citation Format

Share Document